-
1
المؤلفون: Christopher Adams, Van V. Brantner
المصدر: Health Economics. 19:130-141
مصطلحات موضوعية: Drug, Actuarial science, business.industry, Health Policy, media_common.quotation_subject, Survey result, Clinical trial, Drug development, New chemical entity, Therapeutic Categories, Economics, Medicine, business, Pharmaceutical industry, media_common
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ef7bb2eb928a34dc02f78e99ec70468Test
https://doi.org/10.1002/hec.1454Test -
2
المؤلفون: Joseph H. Golec, John A. Vernon, Joseph A. DiMasi
المصدر: Health Economics. 19:1002-1005
مصطلحات موضوعية: Risk, Actuarial science, Drug Industry, Health Policy, Consumption-based capital asset pricing model, Financial risk, Discount points, United States, Capital Financing, Drug development, Cost of capital, Fama–French three-factor model, New chemical entity, Drug Discovery, Costs and Cost Analysis, Economics, Drug Evaluation, Humans, Capital asset pricing model, Drug Approval, Models, Econometric
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dd785834af7719bf1209420f3fd712cTest
https://doi.org/10.1002/hec.1538Test